Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor

Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs,...

Full description

Saved in:
Bibliographic Details
Published inStem cells translational medicine Vol. 9; no. 4; pp. 531 - 542
Main Authors Zimran, Eran, Papa, Luena, Djedaini, Mansour, Patel, Ami, Iancu‐Rubin, Camelia, Hoffman, Ronald
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.04.2020
Oxford University Press
Subjects
Online AccessGet full text
ISSN2157-6564
2157-6580
2157-6580
DOI10.1002/sctm.19-0199

Cover

Abstract Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum‐free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA‐CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA‐treated cultures were able to engraft in immune‐deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA‐mediated ex vivo HSC expansion for gene modification of adult HSCs. Valproic acid (VPA)‐mediated ex vivo expansion of adult bone marrow and mobilized peripheral blood CD34+ cells resulted in a cellular product characterized by high viability, enrichment with CD34+CD45RA‐CD90+ cells, increased aldehyde dehydrogenase (ALDH) activity, robust multipotent clonogenic potential, and decreased mitochondrial potential. VPA‐expanded grafts were able to establish unbiased multilineage human hematopoietic‐cell chimerism in NSG mice at 16 weeks post‐transplantation.
AbstractList Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum‐free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA‐CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA‐treated cultures were able to engraft in immune‐deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA‐mediated ex vivo HSC expansion for gene modification of adult HSCs. Valproic acid (VPA)‐mediated ex vivo expansion of adult bone marrow and mobilized peripheral blood CD34+ cells resulted in a cellular product characterized by high viability, enrichment with CD34+CD45RA‐CD90+ cells, increased aldehyde dehydrogenase (ALDH) activity, robust multipotent clonogenic potential, and decreased mitochondrial potential. VPA‐expanded grafts were able to establish unbiased multilineage human hematopoietic‐cell chimerism in NSG mice at 16 weeks post‐transplantation.
Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum-free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA-CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA-treated cultures were able to engraft in immune-deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA-mediated ex vivo HSC expansion for gene modification of adult HSCs.
Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum-free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA-CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA-treated cultures were able to engraft in immune-deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA-mediated ex vivo HSC expansion for gene modification of adult HSCs.Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum-free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA-CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA-treated cultures were able to engraft in immune-deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA-mediated ex vivo HSC expansion for gene modification of adult HSCs.
Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum‐free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA‐CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA‐treated cultures were able to engraft in immune‐deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA‐mediated ex vivo HSC expansion for gene modification of adult HSCs. Valproic acid (VPA)‐mediated ex vivo expansion of adult bone marrow and mobilized peripheral blood CD34+ cells resulted in a cellular product characterized by high viability, enrichment with CD34+CD45RA‐CD90+ cells, increased aldehyde dehydrogenase (ALDH) activity, robust multipotent clonogenic potential, and decreased mitochondrial potential. VPA‐expanded grafts were able to establish unbiased multilineage human hematopoietic‐cell chimerism in NSG mice at 16 weeks post‐transplantation.
Abstract Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum‐free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA‐CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA‐treated cultures were able to engraft in immune‐deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA‐mediated ex vivo HSC expansion for gene modification of adult HSCs.
Audience Academic
Author Papa, Luena
Patel, Ami
Iancu‐Rubin, Camelia
Djedaini, Mansour
Zimran, Eran
Hoffman, Ronald
AuthorAffiliation 1 Division of Hematology and Oncology Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York NY
2 Hematology Department Hadassah University Center Jerusalem Israel
AuthorAffiliation_xml – name: 2 Hematology Department Hadassah University Center Jerusalem Israel
– name: 1 Division of Hematology and Oncology Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York NY
Author_xml – sequence: 1
  givenname: Eran
  orcidid: 0000-0002-5483-5180
  surname: Zimran
  fullname: Zimran, Eran
  email: eran.zimran@gmail.com
  organization: Hadassah University Center
– sequence: 2
  givenname: Luena
  surname: Papa
  fullname: Papa, Luena
  organization: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
– sequence: 3
  givenname: Mansour
  surname: Djedaini
  fullname: Djedaini, Mansour
  organization: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
– sequence: 4
  givenname: Ami
  surname: Patel
  fullname: Patel, Ami
  organization: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
– sequence: 5
  givenname: Camelia
  surname: Iancu‐Rubin
  fullname: Iancu‐Rubin, Camelia
  organization: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
– sequence: 6
  givenname: Ronald
  surname: Hoffman
  fullname: Hoffman, Ronald
  organization: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31950644$$D View this record in MEDLINE/PubMed
BookMark eNqFkk1v1DAQhiNUREvpjTOyxKUHUmwnseMLUrUqUKkSB8rZcuzJxqskXmxnt_sj-M843bLQSoAvtmcev_Pll9nR6EbIstcEXxCM6fug43BBRI6JEM-yE0oqnrOqxkeHMyuPs7MQVjgtJpig-EV2XBBRYVaWJ9mPq7u1GoN1I1KjQWsPAfxGxdngWhQ7QO006vmueqTSYWPjbnYpM_URdTCo6NbOQrQahQgD0tD3AenknTwYBHdoYzcObW3skEKdDTHVgAwoDXHXqwDIjp1tbHT-Vfa8VX2As4f9NPv28ep28Tm_-fLpenF5k-uqwiRv28oYqgrKddFyVgMRGkogmosKKCMcN40otDC0hIYzYXADylQcqGF1xUVxml3vdY1TK7n2dlB-J52y8t7g_FIqnwrqQTLDhKCaKt7wssRlUzQU2kqrFKKBukpa-V5rGtdqt1V9fxAkWM5TkvOUJBFynlLiP-z59dQMYDSM0av-URKPPaPt5NJtJCe4YGQWOH8Q8O77BCHKwYa56WoENwVJi5IwSoWoE_r2Cbpyk0-TnCmBKSY1J7-ppUoF27F1Ka6eReUlLziuBa1pot78mfch4V9_KQF0D2jvQvDQSm3j_U9Kcrb_WzfePXn0n-YVe3xre9j9k5VfF7cFoYyR4iez2P_m
CitedBy_id crossref_primary_10_1016_j_apsb_2021_12_006
crossref_primary_10_1097_MOH_0000000000000593
crossref_primary_10_1016_j_yexcr_2023_113599
crossref_primary_10_1016_j_jcyt_2021_04_001
crossref_primary_10_3390_epigenomes7040032
crossref_primary_10_1016_j_retram_2024_103444
crossref_primary_10_3390_ph14050423
crossref_primary_10_1182_bloodadvances_2024013047
crossref_primary_10_3390_cancers14071723
crossref_primary_10_1016_j_blre_2021_100853
crossref_primary_10_1016_j_exphem_2023_03_006
crossref_primary_10_1016_j_gde_2020_05_035
crossref_primary_10_1186_s13287_023_03370_z
crossref_primary_10_1186_s43066_021_00165_w
crossref_primary_10_1007_s40778_022_00209_w
crossref_primary_10_3390_cells12060896
crossref_primary_10_1038_s41598_024_72386_z
crossref_primary_10_1016_j_exphem_2022_08_004
crossref_primary_10_3389_fcell_2020_592348
crossref_primary_10_3390_ijms25021187
crossref_primary_10_1016_j_ymthe_2021_09_001
Cites_doi 10.1097/MOH.0000000000000143
10.1016/j.bbmt.2013.12.562
10.1089/scd.2008.0235
10.1182/blood-2003-07-2431
10.1158/0008-5472.CAN-04-3063
10.1182/blood.V89.11.3919
10.1016/S0301-472X(01)00750-0
10.1016/j.stem.2010.07.011
10.1586/17474086.2016.1128321
10.1089/hgtb.2014.043
10.1002/sctm.17-0048
10.1038/sj.bmt.1704928
10.1016/j.stem.2007.10.001
10.1016/j.exphem.2016.04.007
10.1182/bloodadvances.2018024273
10.1182/blood.V96.10.3414
10.1182/blood.V128.22.818.818
10.1126/science.1191536
10.1016/j.jcyt.2012.10.014
10.1016/j.exphem.2009.05.012
10.1126/scitranslmed.aan1145
10.1182/blood-2004-02-0448
10.1182/blood-2006-07-035287
10.1016/j.tcb.2014.04.001
10.1089/hum.2019.009
10.1016/S0301-472X(02)00818-4
10.3324/haematol.2012.079244
10.1155/2019/4067162
10.1038/s41598-017-12360-0
10.1038/ncomms13125
10.1172/JCI70313
10.1089/hum.2016.107
10.1126/science.1201219
10.1016/j.stem.2012.01.006
10.1111/trf.12904
10.1089/scd.2011.0698
ContentType Journal Article
Copyright 2020 The Authors. published by Wiley Periodicals, Inc. on behalf of AlphaMed Press
2020 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.
COPYRIGHT 2020 Oxford University Press
2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2020 The Authors. published by Wiley Periodicals, Inc. on behalf of AlphaMed Press
– notice: 2020 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.
– notice: COPYRIGHT 2020 Oxford University Press
– notice: 2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
DOA
DOI 10.1002/sctm.19-0199
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Collection (ProQuest)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed
CrossRef
MEDLINE - Academic



Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Ex vivo expansion of adult HSCs with valproic acid
EISSN 2157-6580
EndPage 542
ExternalDocumentID oai_doaj_org_article_6d6992c2a7b74404b3b2ef5cabb9be85
10.1002/sctm.19-0199
PMC7103619
A737089282
31950644
10_1002_sctm_19_0199
SCT312661
Genre article
Journal Article
GeographicLocations United States--US
California
GeographicLocations_xml – name: United States--US
– name: California
GroupedDBID 0R~
1OC
24P
53G
5RE
7X7
8FE
8FH
8FI
8FJ
AAHHS
AAKDD
AAPXW
AAVAP
ABEJV
ABPTD
ABUWG
ABXVV
ACCFJ
ACCMX
ACXQS
ADBBV
ADKYN
ADZMN
AEEZP
AENEX
AEQDE
AFKRA
AIWBW
AJAOE
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMNDL
AOIJS
AVUZU
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
DIK
EBD
EBS
EJD
EMOBN
FYUFA
GROUPED_DOAJ
H13
HCIFZ
HMCUK
HYE
HZ~
LK8
M7P
O9-
OK1
OVD
PIMPY
PQQKQ
PROAC
RHI
ROX
RPM
SV3
TOX
UKHRP
WIN
AAMMB
AAYXX
ABGNP
AEFGJ
AGXDD
AIDQK
AIDYY
CITATION
PHGZM
PHGZT
PQGLB
PUEGO
NPM
3V.
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c5501-ff5dd2a327c3f768e19ce4e1c795e26170bb93c9d24eb769d0bead57e2d685793
IEDL.DBID 7X7
ISSN 2157-6564
2157-6580
IngestDate Wed Aug 27 00:08:17 EDT 2025
Wed Aug 20 00:07:21 EDT 2025
Tue Sep 30 15:57:18 EDT 2025
Sun Aug 24 03:49:42 EDT 2025
Sat Sep 20 13:12:00 EDT 2025
Tue Jun 17 21:03:16 EDT 2025
Wed Feb 19 02:29:17 EST 2025
Thu Apr 24 22:56:12 EDT 2025
Wed Oct 01 04:33:24 EDT 2025
Wed Jan 22 16:34:34 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords adult bone marrow
valproic acid
hematopoietic stem cells
mobilized peripheral blood
ex vivo expansion
histone deacetylase inhibitor
Language English
License Attribution-NonCommercial-NoDerivs
http://creativecommons.org/licenses/by-nc-nd/4.0
2020 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5501-ff5dd2a327c3f768e19ce4e1c795e26170bb93c9d24eb769d0bead57e2d685793
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-5483-5180
OpenAccessLink https://www.proquest.com/docview/2390201871?pq-origsite=%requestingapplication%
PMID 31950644
PQID 2390201871
PQPubID 4370291
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_6d6992c2a7b74404b3b2ef5cabb9be85
unpaywall_primary_10_1002_sctm_19_0199
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7103619
proquest_miscellaneous_2341622998
proquest_journals_2390201871
gale_infotracmisc_A737089282
pubmed_primary_31950644
crossref_citationtrail_10_1002_sctm_19_0199
crossref_primary_10_1002_sctm_19_0199
wiley_primary_10_1002_sctm_19_0199_SCT312661
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2020
PublicationDateYYYYMMDD 2020-04-01
PublicationDate_xml – month: 04
  year: 2020
  text: April 2020
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Oxford
PublicationTitle Stem cells translational medicine
PublicationTitleAlternate Stem Cells Transl Med
PublicationYear 2020
Publisher John Wiley & Sons, Inc
Oxford University Press
Publisher_xml – name: John Wiley & Sons, Inc
– name: Oxford University Press
References 2017; 6
2017; 7
2011; 333
2004; 104
2010; 329
2002; 30
2019; 30
2016; 107
2015; 55
1997; 89
2014; 25
2014; 24
2005; 65
2016; 128
2017; 130
2001; 29
2007; 109
2012; 10
2017; 9
2014; 20
2016; 7
2013; 15
2018; 2
2013; 98
2000; 96
2015; 22
2019
2007; 1
2010; 7
2014; 103
2012; 21
2016; 9
2009; 37
2005; 35
2009; 18
2016; 44
2014; 124
Chaurasia (2022022809302389200_sct312661-bib-0008) 2014; 124
Romero-Moya (2022022809302389200_sct312661-bib-0017) 2013; 98
Majeti (2022022809302389200_sct312661-bib-0011) 2007; 1
Papa (2022022809302389200_sct312661-bib-0019) 2019
Rosler (2022022809302389200_sct312661-bib-0002) 2000; 96
De Felice (2022022809302389200_sct312661-bib-0031) 2005; 65
Radtke (2022022809302389200_sct312661-bib-0036) 2017; 9
Papa (2022022809302389200_sct312661-bib-0020) 2019
Boitano (2022022809302389200_sct312661-bib-0024) 2010; 329
Elizade (2022022809302389200_sct312661-bib-0034) 2012; 21
Tanavde (2022022809302389200_sct312661-bib-0003) 2002; 30
Saraf (2022022809302389200_sct312661-bib-0023) 2015; 55
Vannini (2022022809302389200_sct312661-bib-0016) 2016; 7
Simsek (2022022809302389200_sct312661-bib-0018) 2010; 7
Kohli (2022022809302389200_sct312661-bib-0015) 2014; 24
Araki (2022022809302389200_sct312661-bib-0030) 2009; 37
Psatha (2022022809302389200_sct312661-bib-0028) 2017; 6
Psatha (2022022809302389200_sct312661-bib-0006) 2016; 44
Yu (2022022809302389200_sct312661-bib-0007) 2016; 107
Dolatov (2022022809302389200_sct312661-bib-0001) 2012; 10
Arulmozhivarman (2022022809302389200_sct312661-bib-0035) 2017; 7
Araki (2022022809302389200_sct312661-bib-0029) 2007; 109
Carlin (2022022809302389200_sct312661-bib-0027) 2013; 15
Iancu-Rubin (2022022809302389200_sct312661-bib-0010) 2016; 128
Iancu-Rubin (2022022809302389200_sct312661-bib-0009) 2015; 22
Hess (2022022809302389200_sct312661-bib-0013) 2004; 104
Danet (2022022809302389200_sct312661-bib-0037) 2001; 29
Mahmud (2022022809302389200_sct312661-bib-0033) 2014; 20
Baron (2022022809302389200_sct312661-bib-0005) 2016; 9
Moussy (2022022809302389200_sct312661-bib-0038) 2019; 30
Milhem (2022022809302389200_sct312661-bib-0022) 2014; 103
Papa (2022022809302389200_sct312661-bib-0021) 2018; 2
Hoban (2022022809302389200_sct312661-bib-0025) 2017; 130
Gul (2022022809302389200_sct312661-bib-0032) 2009; 18
Lioznov (2022022809302389200_sct312661-bib-0014) 2005; 35
Wang (2022022809302389200_sct312661-bib-0004) 1997; 89
Gu (2022022809302389200_sct312661-bib-0026) 2014; 25
Notta (2022022809302389200_sct312661-bib-0012) 2011; 333
References_xml – volume: 30
  start-page: 1023
  issue: 8
  year: 2019
  end-page: 1034
  article-title: Constraints on human CD34+ cell fate due to lentiviral vectors can be relieved by valproic acid
  publication-title: Hum Gene Ther
– volume: 89
  start-page: 3919
  issue: 11
  year: 1997
  end-page: 3924
  article-title: Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID‐repopulating assay
  publication-title: Blood
– volume: 22
  start-page: 279
  year: 2015
  end-page: 285
  article-title: Role of epigenetic reprogramming in hematopoietic stem cell function
  publication-title: Curr Opin Hematol
– volume: 107
  start-page: 729
  year: 2016
  end-page: 740
  article-title: Gene editing of human hematopoietic stem and progenitor cells: promise and potential hurdles
  publication-title: Human Gene Ther
– volume: 29
  start-page: 1465
  year: 2001
  end-page: 1473
  article-title: Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansion
  publication-title: Exp Hematol
– volume: 18
  start-page: 831
  issue: 6
  year: 2009
  end-page: 838
  article-title: Valproic acid increases CXCR4 expression in hematopoietic stem/progenitor cells by chromatin remodeling
  publication-title: Stem Cells Dev
– volume: 10
  start-page: 120
  issue: 2
  year: 2012
  end-page: 137
  article-title: Hematopoiesis: a human perspective
  publication-title: Cell Stem Cell
– volume: 130
  start-page: 3341
  year: 2017
  article-title: Aryl hydrocarbon receptor antagonists expand adult hematopoietic stem cells from mobilized peripheral blood and bone marrow and increase the dose of CRISPR/Cas9 gene‐edited NSG‐repopulating cells
  publication-title: Blood
– volume: 15
  start-page: 224
  issue: 2
  year: 2013
  end-page: 230
  article-title: T‐cell potential of human adult and cord blood hemopoietic stem cells expanded with the use of aryl hydrocarbon receptor antagonists
  publication-title: Cytotherapy
– volume: 104
  start-page: 1648
  issue: 6
  year: 2004
  end-page: 1655
  article-title: Functional characterization of highly purified human hematopoietic human repopulating cells isolated according to aldehyde dehydrogenase activity
  publication-title: Blood
– volume: 35
  start-page: 909
  issue: 9
  year: 2005
  end-page: 914
  article-title: Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants
  publication-title: Bone Marrow Transplant
– volume: 329
  start-page: 1345
  year: 2010
  end-page: 1348
  article-title: Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells
  publication-title: Science
– volume: 103
  start-page: 4102
  issue: 11
  year: 2014
  end-page: 4110
  article-title: Modification of hematopoietic stem cell fate by 5aza2'deoxycytidine and trichostatin A
  publication-title: Blood
– volume: 44
  start-page: 528
  year: 2016
  end-page: 539
  article-title: Optimizing autologous cell grafts to improve stem cell gene therapy
  publication-title: Exp Hematol
– volume: 7
  year: 2016
  article-title: Specification of haematopoieitc stem cell fate via modulation of mitochondrial activity
  publication-title: Nat Commun
– volume: 124
  start-page: 2378
  issue: 6
  year: 2014
  end-page: 2395
  article-title: Epigenetic reprogramming induces the expansion of cord blood stem cells
  publication-title: J Clin Invest
– volume: 7
  start-page: 380
  issue: 3
  year: 2010
  end-page: 390
  article-title: The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche
  publication-title: Cell Stem Cell
– volume: 9
  start-page: 1
  issue: 414
  year: 2017
  end-page: 10
  article-title: A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates
  publication-title: Sci Trans Med
– volume: 96
  start-page: 3414
  issue: 10
  year: 2000
  end-page: 3421
  article-title: An in vivo competitive repopulation assay for various sources of human hematopoitic stem cells
  publication-title: Blood
– volume: 25
  start-page: 221
  issue: 4
  year: 2014
  end-page: 231
  article-title: Engraftment and lineage potential of adult hematopoietic stem and progenitor cells is compromised following short‐term culture in the presencce of an aryl hydrocarbon receptor antagonist
  publication-title: Hum Gene Ther Methods
– volume: 37
  start-page: 1084
  year: 2009
  end-page: 1095
  article-title: Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues
  publication-title: Exp Hematol
– volume: 333
  start-page: 218
  year: 2011
  end-page: 221
  article-title: Isolation of single human hematopoietic stem cells capable of long‐term multiliniage engraftment
  publication-title: Science
– year: 2019
  article-title: Mitochondrial role in stemness and differentiation of hematopoietic stem cells
  publication-title: Stem Cells Int
– volume: 21
  start-page: 2581
  issue: 4
  year: 2012
  end-page: 2591
  article-title: Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells
  publication-title: Stem Cells Dev
– volume: 30
  start-page: 816
  year: 2002
  end-page: 823
  article-title: Human stem‐progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood
  publication-title: Exp Hematol
– year: 2019
  article-title: Ex vivo HSC expansion challenges the paradigm of unidirectional human hematopoiesis
  publication-title: Ann N Y Acad Sci
– volume: 128
  start-page: 818
  year: 2016
  article-title: Preclinical development of a cord blood (CB)‐derived hematopoietic stem cell (HSC) product for allogeneic transplantation in patients with hematological malignancies
  publication-title: Blood
– volume: 9
  start-page: 297
  issue: 3
  year: 2016
  end-page: 314
  article-title: Methods of expansion of human cord blood cells: challenges, successes and clinical implications
  publication-title: Exp Rev Hematol
– volume: 2
  start-page: 2766
  issue: 20
  year: 2018
  end-page: 2779
  article-title: Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation
  publication-title: Blood Adv
– volume: 55
  start-page: 864
  year: 2015
  end-page: 874
  article-title: Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers
  publication-title: Transfusion
– volume: 109
  start-page: 3570
  issue: 8
  year: 2007
  end-page: 3578
  article-title: Chromatin‐modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential
  publication-title: Blood
– volume: 20
  start-page: 480
  year: 2014
  end-page: 489
  article-title: Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells
  publication-title: Biol Blood Marrow Transplant
– volume: 98
  start-page: 1022
  issue: 7
  year: 2013
  end-page: 1029
  article-title: Cord blood‐derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function
  publication-title: Haematologica
– volume: 1
  start-page: 635
  year: 2007
  end-page: 645
  article-title: Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood
  publication-title: Cell Stem Cell
– volume: 6
  start-page: 1852
  issue: 10
  year: 2017
  end-page: 1858
  article-title: Brief report: a differential transcriptomic profile of ex vivo expanded adult human hematopoietic stem cells empowers them for engraftment better than their surface phenotype
  publication-title: Stem Cell Trans
– volume: 24
  start-page: 479
  issue: 8
  year: 2014
  end-page: 487
  article-title: Surviving change: the metabolic journey of hematopoietic stem cells
  publication-title: Trends Cell Biol
– volume: 65
  start-page: 1505
  issue: 4
  year: 2005
  end-page: 1513
  article-title: Histone deacetylase inhibitor valproic acid enhances the cytokine‐induced expansion of human hematopoietic stem cells
  publication-title: Cancer Res
– volume: 7
  issue: 1
  year: 2017
  article-title: Zebrafish in‐vivo screening for compounds amplifying hematopoietic stem and progenitor cells: preclinical validation in human CD34+ stem and progenitor cells
  publication-title: Sci Rep
– volume: 22
  start-page: 279
  year: 2015
  ident: 2022022809302389200_sct312661-bib-0009
  article-title: Role of epigenetic reprogramming in hematopoietic stem cell function
  publication-title: Curr Opin Hematol
  doi: 10.1097/MOH.0000000000000143
– volume: 20
  start-page: 480
  year: 2014
  ident: 2022022809302389200_sct312661-bib-0033
  article-title: Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2013.12.562
– volume: 18
  start-page: 831
  issue: 6
  year: 2009
  ident: 2022022809302389200_sct312661-bib-0032
  article-title: Valproic acid increases CXCR4 expression in hematopoietic stem/progenitor cells by chromatin remodeling
  publication-title: Stem Cells Dev
  doi: 10.1089/scd.2008.0235
– volume: 103
  start-page: 4102
  issue: 11
  year: 2014
  ident: 2022022809302389200_sct312661-bib-0022
  article-title: Modification of hematopoietic stem cell fate by 5aza2’deoxycytidine and trichostatin A
  publication-title: Blood
  doi: 10.1182/blood-2003-07-2431
– volume: 65
  start-page: 1505
  issue: 4
  year: 2005
  ident: 2022022809302389200_sct312661-bib-0031
  article-title: Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-3063
– volume: 89
  start-page: 3919
  issue: 11
  year: 1997
  ident: 2022022809302389200_sct312661-bib-0004
  article-title: Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating assay
  publication-title: Blood
  doi: 10.1182/blood.V89.11.3919
– volume: 29
  start-page: 1465
  year: 2001
  ident: 2022022809302389200_sct312661-bib-0037
  article-title: Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansion
  publication-title: Exp Hematol
  doi: 10.1016/S0301-472X(01)00750-0
– volume: 7
  start-page: 380
  issue: 3
  year: 2010
  ident: 2022022809302389200_sct312661-bib-0018
  article-title: The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2010.07.011
– volume: 9
  start-page: 297
  issue: 3
  year: 2016
  ident: 2022022809302389200_sct312661-bib-0005
  article-title: Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications
  publication-title: Exp Rev Hematol
  doi: 10.1586/17474086.2016.1128321
– volume: 25
  start-page: 221
  issue: 4
  year: 2014
  ident: 2022022809302389200_sct312661-bib-0026
  article-title: Engraftment and lineage potential of adult hematopoietic stem and progenitor cells is compromised following short-term culture in the presencce of an aryl hydrocarbon receptor antagonist
  publication-title: Hum Gene Ther Methods
  doi: 10.1089/hgtb.2014.043
– volume: 6
  start-page: 1852
  issue: 10
  year: 2017
  ident: 2022022809302389200_sct312661-bib-0028
  article-title: Brief report: a differential transcriptomic profile of ex vivo expanded adult human hematopoietic stem cells empowers them for engraftment better than their surface phenotype
  publication-title: Stem Cell Trans
  doi: 10.1002/sctm.17-0048
– volume: 35
  start-page: 909
  issue: 9
  year: 2005
  ident: 2022022809302389200_sct312661-bib-0014
  article-title: Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants
  publication-title: Bone Marrow Transplant
  doi: 10.1038/sj.bmt.1704928
– volume: 1
  start-page: 635
  year: 2007
  ident: 2022022809302389200_sct312661-bib-0011
  article-title: Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2007.10.001
– volume: 44
  start-page: 528
  year: 2016
  ident: 2022022809302389200_sct312661-bib-0006
  article-title: Optimizing autologous cell grafts to improve stem cell gene therapy
  publication-title: Exp Hematol
  doi: 10.1016/j.exphem.2016.04.007
– volume: 2
  start-page: 2766
  issue: 20
  year: 2018
  ident: 2022022809302389200_sct312661-bib-0021
  article-title: Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation
  publication-title: Blood Adv
  doi: 10.1182/bloodadvances.2018024273
– volume: 96
  start-page: 3414
  issue: 10
  year: 2000
  ident: 2022022809302389200_sct312661-bib-0002
  article-title: An in vivo competitive repopulation assay for various sources of human hematopoitic stem cells
  publication-title: Blood
  doi: 10.1182/blood.V96.10.3414
– volume: 128
  start-page: 818
  year: 2016
  ident: 2022022809302389200_sct312661-bib-0010
  article-title: Preclinical development of a cord blood (CB)-derived hematopoietic stem cell (HSC) product for allogeneic transplantation in patients with hematological malignancies
  publication-title: Blood
  doi: 10.1182/blood.V128.22.818.818
– volume: 329
  start-page: 1345
  year: 2010
  ident: 2022022809302389200_sct312661-bib-0024
  article-title: Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells
  publication-title: Science
  doi: 10.1126/science.1191536
– volume: 15
  start-page: 224
  issue: 2
  year: 2013
  ident: 2022022809302389200_sct312661-bib-0027
  article-title: T-cell potential of human adult and cord blood hemopoietic stem cells expanded with the use of aryl hydrocarbon receptor antagonists
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2012.10.014
– volume: 37
  start-page: 1084
  year: 2009
  ident: 2022022809302389200_sct312661-bib-0030
  article-title: Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues
  publication-title: Exp Hematol
  doi: 10.1016/j.exphem.2009.05.012
– volume: 9
  start-page: 1
  issue: 414
  year: 2017
  ident: 2022022809302389200_sct312661-bib-0036
  article-title: A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates
  publication-title: Sci Trans Med
  doi: 10.1126/scitranslmed.aan1145
– volume: 104
  start-page: 1648
  issue: 6
  year: 2004
  ident: 2022022809302389200_sct312661-bib-0013
  article-title: Functional characterization of highly purified human hematopoietic human repopulating cells isolated according to aldehyde dehydrogenase activity
  publication-title: Blood
  doi: 10.1182/blood-2004-02-0448
– volume: 109
  start-page: 3570
  issue: 8
  year: 2007
  ident: 2022022809302389200_sct312661-bib-0029
  article-title: Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential
  publication-title: Blood
  doi: 10.1182/blood-2006-07-035287
– volume: 24
  start-page: 479
  issue: 8
  year: 2014
  ident: 2022022809302389200_sct312661-bib-0015
  article-title: Surviving change: the metabolic journey of hematopoietic stem cells
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2014.04.001
– volume: 30
  start-page: 1023
  issue: 8
  year: 2019
  ident: 2022022809302389200_sct312661-bib-0038
  article-title: Constraints on human CD34+ cell fate due to lentiviral vectors can be relieved by valproic acid
  publication-title: Hum Gene Ther
  doi: 10.1089/hum.2019.009
– volume: 30
  start-page: 816
  year: 2002
  ident: 2022022809302389200_sct312661-bib-0003
  article-title: Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood
  publication-title: Exp Hematol
  doi: 10.1016/S0301-472X(02)00818-4
– volume: 98
  start-page: 1022
  issue: 7
  year: 2013
  ident: 2022022809302389200_sct312661-bib-0017
  article-title: Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function
  publication-title: Haematologica
  doi: 10.3324/haematol.2012.079244
– year: 2019
  ident: 2022022809302389200_sct312661-bib-0019
  article-title: Mitochondrial role in stemness and differentiation of hematopoietic stem cells
  publication-title: Stem Cells Int
  doi: 10.1155/2019/4067162
– volume: 7
  issue: 1
  year: 2017
  ident: 2022022809302389200_sct312661-bib-0035
  article-title: Zebrafish in-vivo screening for compounds amplifying hematopoietic stem and progenitor cells: preclinical validation in human CD34+ stem and progenitor cells
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-12360-0
– volume: 7
  year: 2016
  ident: 2022022809302389200_sct312661-bib-0016
  article-title: Specification of haematopoieitc stem cell fate via modulation of mitochondrial activity
  publication-title: Nat Commun
  doi: 10.1038/ncomms13125
– volume: 124
  start-page: 2378
  issue: 6
  year: 2014
  ident: 2022022809302389200_sct312661-bib-0008
  article-title: Epigenetic reprogramming induces the expansion of cord blood stem cells
  publication-title: J Clin Invest
  doi: 10.1172/JCI70313
– volume: 107
  start-page: 729
  year: 2016
  ident: 2022022809302389200_sct312661-bib-0007
  article-title: Gene editing of human hematopoietic stem and progenitor cells: promise and potential hurdles
  publication-title: Human Gene Ther
  doi: 10.1089/hum.2016.107
– volume: 333
  start-page: 218
  year: 2011
  ident: 2022022809302389200_sct312661-bib-0012
  article-title: Isolation of single human hematopoietic stem cells capable of long-term multiliniage engraftment
  publication-title: Science
  doi: 10.1126/science.1201219
– volume: 10
  start-page: 120
  issue: 2
  year: 2012
  ident: 2022022809302389200_sct312661-bib-0001
  article-title: Hematopoiesis: a human perspective
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2012.01.006
– year: 2019
  ident: 2022022809302389200_sct312661-bib-0020
  article-title: Ex vivo HSC expansion challenges the paradigm of unidirectional human hematopoiesis
  publication-title: Ann N Y Acad Sci
– volume: 55
  start-page: 864
  year: 2015
  ident: 2022022809302389200_sct312661-bib-0023
  article-title: Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers
  publication-title: Transfusion
  doi: 10.1111/trf.12904
– volume: 21
  start-page: 2581
  issue: 4
  year: 2012
  ident: 2022022809302389200_sct312661-bib-0034
  article-title: Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells
  publication-title: Stem Cells Dev
  doi: 10.1089/scd.2011.0698
– volume: 130
  start-page: 3341
  year: 2017
  ident: 2022022809302389200_sct312661-bib-0025
  article-title: Aryl hydrocarbon receptor antagonists expand adult hematopoietic stem cells from mobilized peripheral blood and bone marrow and increase the dose of CRISPR/Cas9 gene-edited NSG-repopulating cells
  publication-title: Blood
SSID ssj0000696920
Score 2.3264675
Snippet Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to...
Abstract Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their...
SourceID doaj
unpaywall
pubmedcentral
proquest
gale
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 531
SubjectTerms adult bone marrow
Aldehyde dehydrogenase
Blood
Bone marrow
CD34 antigen
CD45RA antigen
CD90 antigen
Cord blood
Cytokines
Divalproex
Ethylenediaminetetraacetic acid
ex vivo expansion
Expansion
Experiments
Flow cytometry
Genetically modified organisms
Granulocytes
Hematology
Hematopoietic stem cells
Histone deacetylase
histone deacetylase inhibitor
Kinases
Laboratories
Ligands
Lymphocytes T
Membrane potential
Mitochondria
mobilized peripheral blood
Ontology
Peripheral blood
Stem cell transplantation
Stem cells
T cells
Tissue‐specific Progenitor and Stem Cells
Umbilical cord
Valproic acid
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQJQQXxDeBgowEXCB0YydxfCxVqwoJLrRSb5btTNRI22TV3S3dH8F_ZsbOhl0Q9MI1dnZjz3jmzWj8hrE3E3Bl4XyVKkD4lgtXpZWkEiirGyWFLapQVfnla3l8mn8-K842Wn1RTVikB44bt1fWpdbCC6tc4LJz0gloCm-d0w6qwF6KbmwjmIo2WJc6cDKiS1MpgpZ8qHpHC7A394uLj3R5J1K-_vJHgbb_T-O84Z1-r5y8s-xmdvXdTqfb6Da4p6P77N6AK_l-XM8Ddgu6h-x27DS5esR-HF7jsafMGLddzan6dZ2N5X3DEQVy8nAxMcjpsgP1lKChQNDBA7VrP-tbuvPIifyZU8p_ziNzB9QcrvlVe9VzSuxyywOPcQe8RpMLixVidOBtd946tCCXj9np0eHJwXE6dGJIPUYwWdo0RV0LK4XyssEABTLtIYfMK11A4HRHaUiva5GDU6WuJw41tFAg6rIq0AQ8YTsd_ukzxnMJqsrx10piNsu08_gAzQAIhEauqRL2fi0P4weacuqWMTWRYFkYkp7JtCHpJeztOHsW6Tn-Mu8TiXacQ6Ta4QGqmhlUzdykagnbJcUwdPTxkzweRG_2lVSTSmPkisNrhTGDIZgbITUC8gzD0oS9HofpTSpu66Bf0hxExQJxAS7-adSv8UMltelFzJowtaV5WyvZHuna80ATjthR4gYn7N2oozfs0YegwP-cZL4dnMiMUN3z_7GlL9hdQQmMUAq1y3YWl0t4iShv4V6FA_0THblQJA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdGJ8Re-GYEBjIS8AIpjZ3E8WOZNk1ITEi00niyYsdhFSWp2nSs_A_8z9w5H5AiPh54i2InsU_n8-8u598R8nRkdRxpk_jCAnwLmU78hGMKVCpzwVkaJS6r8u1pfDIN35xFZztk0p6FQfZiDFmvGlGuhjVjRBeCw7XiLDgu-UWW15a_-d_PXq1M9XmI53ICKa-Q3Rh_Ow3I7vT03fgD1pkLIuEDhAl_XCejJh9--_HeTuUI_X812z_tW9s5ldfWxSLdfEnn8z7udRvX8Q2ybqdc56t8Gq4rPTRft9gg_7dMbpLrDdKl41o1b5EdW9wmV-val5s75NvRJRgijNXRtMgo5uO28WFa5hRwKcU9tw5VUjx-gVUusMlRhlBHNlsuyhmewqQ4eOpGT2suEZtRe0kvZhclxVAzTaljVi4szWATsNUGvAZLZ8X5TINNW94l0-OjyeGJ39SG8A34VIGf51GWsZQzYXgOLpMNpLGhDYyQkXUs81pLbmTGQqtFLLORhjUTCcuyOInAKN0jgwI-ep_QkFuRhPC2GLnWAqkN3ADDZBmANZ0nHnnR6oEyDXE61u-Yq5rymSkUsAqkQgF75FnXe1EThvym32tUqa4P0ny7G-Xyo2qshoqzWEpmWCq0I3LUXDObRyaFyWmbRB45QIVUaIxgSAZMg1FjwcUokeBLQ3OrqKrVHcW4BBchAEfZI0-6ZnwS0-0KW66xD-B0BkgFJr9f63U3UI6FgwFFe0T0NL43k35LMTt3xOWAZjkI2CPPu7XxFxm9dLr9x07q_eGEB4gzH_zrex-SPYZhE5eAdUAG1XJtHwG2rPTjxlR8B-6QfHk
  priority: 102
  providerName: Unpaywall
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagHOCCingFCjIScIHQjZ3E8bFUrSokEBKt1JtlOxMaaUlW--jjR_Q_d8bJpk0RIK7xxInteXwejT8z9nYCLs-cL2IFCN9S4Yq4kFQCZXWlpLBZEaoqv37LD47SL8fZcZ9wo7MwHT_EkHAjywj-mgzcusX2NWnowi9_faITOInWd9m9hAI_MTun34ccyyTXuQ7MjBjYVIzQJe1r37GL7ZsdjKJSIO__3UXfiFG36yfvr5qZvTiz0-kY44Ygtb_JHvboku906vCI3YHmMbvcO0eTp6wYt03JqfJ1nYnlbcURAXKKbl1SkNNBB7pPgpoCOQcPtK7trK3pvCMn4mdO6f4F71g7oORwzk_r05ZTUpdbHjiMG-AlultYXiA-B143J7VD7zF_wo729w53D-L-FobY4-4liasqK0thpVBeVrg5gUR7SCHxSmcQ-Nyd09LrUqTgVK7LiUPtzBSIMi8yNP-nbKPBjz5nPJWgihR7y4nVLNHO4wN0ASAQFrmqiNiH9SoY31OU000ZU9ORKwtDa2YSbWjNIvZukJ511Bx_kPtMCzrIEKF2eNDOf5rePk1e5loLL6xygTLRSSegyrzFwTkosohtkToYMnv8JY9G6M2OkmpSaNy1YvNaTUzvBBZGSI1gPMEtacTeDM30JhW2NdCuSAYRsUBMgIN_1mnV8KOSruhFvBoxNdK30UjGLU19EijCETdKnOCIvR808x9z9DGo7V-FzI_dQ5kQonvxf-Iv2QNBaYpQ8LTFNpbzFbxCLLd0r4PBXgGwHkYW
  priority: 102
  providerName: Wiley-Blackwell
Title Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fsctm.19-0199
https://www.ncbi.nlm.nih.gov/pubmed/31950644
https://www.proquest.com/docview/2390201871
https://www.proquest.com/docview/2341622998
https://pubmed.ncbi.nlm.nih.gov/PMC7103619
https://stemcellsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/sctm.19-0199
https://doaj.org/article/6d6992c2a7b74404b3b2ef5cabb9be85
UnpaywallVersion publishedVersion
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2157-6580
  dateEnd: 20211231
  omitProxy: true
  ssIdentifier: ssj0000696920
  issn: 2157-6564
  databaseCode: DOA
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2157-6580
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000696920
  issn: 2157-6564
  databaseCode: DIK
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2157-6580
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000696920
  issn: 2157-6564
  databaseCode: RPM
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVASL
  databaseName: Oxford Journals Open Access Collection
  customDbUrl:
  eissn: 2157-6580
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000696920
  issn: 2157-6564
  databaseCode: TOX
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://academic.oup.com/journals/
  providerName: Oxford University Press
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2157-6580
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000696920
  issn: 2157-6564
  databaseCode: 7X7
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2157-6580
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000696920
  issn: 2157-6564
  databaseCode: BENPR
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVWIB
  databaseName: KBPluse Wiley Online Library: Open Access
  customDbUrl:
  eissn: 2157-6580
  dateEnd: 20211231
  omitProxy: true
  ssIdentifier: ssj0000696920
  issn: 2157-6564
  databaseCode: AVUZU
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 2157-6580
  dateEnd: 20211231
  omitProxy: true
  ssIdentifier: ssj0000696920
  issn: 2157-6564
  databaseCode: 24P
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bb9MwFLbYJsReEHcCozIS8AJhjZ3E8RPqpk4TElUFq1SerPgSVqlLSi9j_RH8Z85x0oyCGI-NT9s4Pj7-_OX4O4S86jqdJtpkoXAA32KmszDjmAKVy0JwlieZz6r8NEhPR_HHcTJuCLdFk1a5iYk-UNvKIEd-yGBzzrCCXPRh9j3EqlH4drUpobFD9iKAKujVYixajqWbylR6ZUZY2EQI0CVuct8hDhwuzPLiPR7hqYVfr1clL97_d4j-bY36M3_yzqqc5esf-XS6jXH9InVyj9xt0CXt1e5wn9xy5QNyu643uX5IfvavYPIjP0bz0lLMgd1wsrQqKGBBiutcTQ9SPPKAlSWwyct0UC_wWs2qCZ58pCgBTZH4X9Bav8NZ6q7o5eSyokjv0px6NePSUQuB1y3XgNQdnZTnEw1xZP6IjE76Z8enYVOPITSwj4nCokisZTlnwvACtikuksbFLjJCJs4ru2stuZGWxU6LVNquBj9NhGM2zRIIBI_Jbgl_-pTQmDuRxfBrKeqbRVIbuADBwDEASLrIAvJ2Mx7KNGLlWDNjqmqZZaZw9FQkFY5eQF631rNapOMfdkc4tK0NSmv7C9X8m2pmqkptKiUzLBfaiydqrpkrEpND57TLkoAcoGMoDABwSwamo1E9wUU3k7B_heaNw6gmHCzUtfMG5GXbjN_EFLfSVSu0AWzMAB1A55_U_tXeKMdivYBcAyK2PG-rJ9st5eTci4UDguTwgAPypvXR_zyjd96BbzRSX47PeITY7tnN3X1O9hkSFD7V6YDsLucr9wJQ3FJ3yA6Lhx0_YTtk76g_GH7ueEYEPo0Gw97XX3FLS80
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlQuiDeBAkaiXCA0sZM4PiBUSqstfVzYSntzY8ehKy3Jso-2-yP4K_xGZpxHWRDl1Gvs7MaeyefPk_E3hLwKrE5ibVJfWKBvEdOpn3JMgcpkITjL4tRlVR4eJb3j6PMgHqyQn-1ZGEyrbDHRAXVeGYyRbzLYnDOsIBd-GH_3sWoUfl1tS2jUbrFvF-ewZZu-3_sE9t1gbHenv93zm6oCvgE2HvpFEec5yzgThhdAtm0ojY1saISMrdMn11pyI3MWWS0SmQcaZjsWluVJGgsUXwLIvxHxIEKtfjEQXUwnSGQinRIkLKTCB6oUNbn2gDubUzP79g6PDNVCs5eroCsW8PeS8Nua-Ge-5tq8HGeL82w0WubUblHcvUNuN2yWbtXud5es2PIeuVnXt1zcJz92LgBsMB5HszKnmHPbxoBpVVDgnhTX1TocSfGIBVaywCYnC0KdoGw1roZ40pKi5DTFDw1TWuuF2JzaC3o2PKsohpNpRp16cmlpDkBvZwvYGVg6LE-HGnBr8oAcX4ulHpLVEv70MaERtyKN4NcS1FMLpTZwAcDHMiBkukg98qa1hzKNODrW6BipWtaZKbSeCqVC63lko-s9rkVB_tHvI5q264NS3u5CNfmqGmRQSZ5IyQzLhHZijZprZovYZDA4bdPYI-voGAoBBx7JwOtv1JbgIkgl7JehuXUY1cDPVF2-LB552TXjnZhSV9pqjn2AizNgIzD4R7V_dQ_KsTgwMGWPiCXPWxrJcks5PHXi5MBYOUywR153PvqfOXrrHPjKTurLdp-HyCWfXD3cF2St1z88UAd7R_tPyS2GwRGXZrVOVmeTuX0GDHKmn7vXlpKT68aJX6Iug80
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtQwELWqIi4viDuBAkaivEDYjZ3E8QNCpe2qpVAh0Ur75saOQyMtybKXtvsR_BBfx4xzKQuiPPU1dnZjz-T4eDI-Q8iLvtVxpE3iCwv0LWQ68ROOKVCpzAVnaZS4rMpP-_HOYfhhGA1XyM_2LAymVbaY6IA6qwzGyHsMNucMK8gFvbxJi_i8NXg3_u5jBSn80tqW06hdZM8uTmH7Nn27uwW2XmdssH2wueM3FQZ8A8w88PM8yjKWciYMz4F420AaG9rACBlZp1WuteRGZiy0WsQy62uY-UhYlsVJJFCICeD_iuAhx3QyMRRdfKcfy1g6VUhYVIUPtCls8u4Bg3pTM_v2Bo8P1aKz5yuiKxzw9_Lw2_r4Z-7m9Xk5Then6Wi0zK_dAjm4RW42zJZu1K54m6zY8g65Wte6XNwlP7bPAHgwNkfTMqOYf9vGg2mVU-ChFNfYOjRJ8bgFVrXAJicRQp24bDWuCjx1SVF-muJHhymttUNsRu0ZPSlOKoqhZZpSp6RcWpoB6NvZAnYJlhblcaEBwyb3yOGlWOo-WS3hTx8SGnIrkhB-LUZttUBqAxcAiCwDcqbzxCOvWnso0wilY72OkaolnplC66lAKrSeR9a73uNaIOQf_d6jabs-KOvtLlSTr6pBCRVnsZTMsFRoJ9youWY2j0wKg9M2iTyyho6hEHzgkQxAgVEbgot-ImHvDM2tw6gGiqbq_MXxyPOuGe_E9LrSVnPsA7ycATOBwT-o_at7UI6FgoE1e0Qsed7SSJZbyuLYCZUDe-UwwR552fnof-botXPgCzupL5sHPEBe-eji4T4j1wAh1Mfd_b3H5AbDOInLuFojq7PJ3D4BMjnTT91bS8nRZcPEL9rhiAg
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdGJ8Re-GYEBjIS8AIpjZ3E8WOZNk1ITEi00niyYsdhFSWp2nSs_A_8z9w5H5AiPh54i2InsU_n8-8u598R8nRkdRxpk_jCAnwLmU78hGMKVCpzwVkaJS6r8u1pfDIN35xFZztk0p6FQfZiDFmvGlGuhjVjRBeCw7XiLDgu-UWW15a_-d_PXq1M9XmI53ICKa-Q3Rh_Ow3I7vT03fgD1pkLIuEDhAl_XCejJh9--_HeTuUI_X812z_tW9s5ldfWxSLdfEnn8z7udRvX8Q2ybqdc56t8Gq4rPTRft9gg_7dMbpLrDdKl41o1b5EdW9wmV-val5s75NvRJRgijNXRtMgo5uO28WFa5hRwKcU9tw5VUjx-gVUusMlRhlBHNlsuyhmewqQ4eOpGT2suEZtRe0kvZhclxVAzTaljVi4szWATsNUGvAZLZ8X5TINNW94l0-OjyeGJ39SG8A34VIGf51GWsZQzYXgOLpMNpLGhDYyQkXUs81pLbmTGQqtFLLORhjUTCcuyOInAKN0jgwI-ep_QkFuRhPC2GLnWAqkN3ADDZBmANZ0nHnnR6oEyDXE61u-Yq5rymSkUsAqkQgF75FnXe1EThvym32tUqa4P0ny7G-Xyo2qshoqzWEpmWCq0I3LUXDObRyaFyWmbRB45QIVUaIxgSAZMg1FjwcUokeBLQ3OrqKrVHcW4BBchAEfZI0-6ZnwS0-0KW66xD-B0BkgFJr9f63U3UI6FgwFFe0T0NL43k35LMTt3xOWAZjkI2CPPu7XxFxm9dLr9x07q_eGEB4gzH_zrex-SPYZhE5eAdUAG1XJtHwG2rPTjxlR8B-6QfHk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expansion+and+preservation+of+the+functional+activity+of+adult+hematopoietic+stem+cells+cultured+ex+vivo+with+a+histone+deacetylase+inhibitor&rft.jtitle=Stem+cells+translational+medicine&rft.au=Zimran%2C+Eran&rft.au=Papa%2C+Luena&rft.au=Djedaini%2C+Mansour&rft.au=Patel%2C+Ami&rft.date=2020-04-01&rft.eissn=2157-6580&rft.volume=9&rft.issue=4&rft.spage=531&rft_id=info:doi/10.1002%2Fsctm.19-0199&rft_id=info%3Apmid%2F31950644&rft.externalDocID=31950644
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2157-6564&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2157-6564&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2157-6564&client=summon